RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 112 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $86,000 | -32.8% | 31,418 | -18.5% | 0.03% | -19.0% |
| Q1 2017 | $128,000 | -43.4% | 38,559 | -59.4% | 0.04% | -30.0% |
| Q4 2016 | $226,000 | -56.3% | 94,869 | -59.1% | 0.06% | -36.8% |
| Q2 2016 | $517,000 | -71.3% | 231,756 | -73.2% | 0.10% | -63.3% |
| Q1 2016 | $1,800,000 | -52.5% | 865,197 | -30.9% | 0.26% | -36.5% |
| Q4 2015 | $3,791,000 | +0.3% | 1,251,289 | -18.2% | 0.41% | +12.1% |
| Q3 2015 | $3,778,000 | -32.6% | 1,529,481 | -12.5% | 0.36% | -33.6% |
| Q2 2015 | $5,609,000 | +377.4% | 1,747,400 | +430.9% | 0.55% | +376.5% |
| Q1 2015 | $1,175,000 | +152.1% | 329,146 | +60.4% | 0.12% | +161.4% |
| Q4 2014 | $466,000 | -75.2% | 205,169 | -78.8% | 0.04% | -73.0% |
| Q3 2014 | $1,879,000 | -30.0% | 968,599 | +31.0% | 0.16% | -22.7% |
| Q2 2014 | $2,684,000 | +89.3% | 739,492 | +102.3% | 0.21% | +124.5% |
| Q1 2014 | $1,418,000 | +3.1% | 365,562 | -24.2% | 0.09% | +44.6% |
| Q4 2013 | $1,375,000 | -34.0% | 482,557 | -17.0% | 0.06% | -31.6% |
| Q3 2013 | $2,082,000 | +31.6% | 581,485 | +22.7% | 0.10% | +41.8% |
| Q2 2013 | $1,582,000 | – | 473,737 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |